Aehr stock jumps on beat and raise amid AI demand

What happened

Aehr Test Systems shares rose about 15% before Tuesday’s market open after first-quarter revenue reached $33 million, up 200% year over year, and adjusted earnings were 28 cents per share. The company raised its fiscal 2027 revenue outlook to $150 million, citing demand for semiconductor testing systems used with AI chips.

Confirmed

Global impact / market context

Higher guidance and strong quarterly results suggest AI-chip demand is translating into sales for Aehr’s testing equipment. If demand continues, rising equipment shipments could support revenue growth; if customer capacity plans or product evaluations do not convert into orders, the raised outlook may prove harder to achieve.

Analyst inference

Aehr linked demand to an existing AI processor customer expanding capacity and to growing sales of systems used to test packaged processors. It is also evaluating production equipment with a major chip supplier, but the article does not report a completed order from that evaluation.

Confirmed

What to watch

1. Track whether revenue rises sequentially through the remaining fiscal 2027 quarters, as the chief executive expects, and whether reported results support the $150 million outlook. Analyst inference
2. Watch for an outcome from the production evaluation and whether the planned Taiwan system installation occurs in early 2027; these are steps toward production use, not confirmed orders. Analyst inference
3. Follow shipments to the hyperscale customer and capacity expansion by the leading AI processor customer, since these reported demand sources could influence equipment sales. Analyst inference

Evidence

• seekingalpha.com